Central administration of the neurotensin receptor antagonist, SR48692, modulates diurnal and stress-related hypothalamic-pituitary-adrenal activity

Neuroendocrinology

Volumn 66, Issue 2, 1997, Pages 75-85

  Rowe, Wayne B ^a   Nicot, Arnaud ^b   Sharma, Shakti ^a   Gully, Danielle ^c   Walker, Claire Dominique ^a   Rostène, William H ^b   Meaney, Michael J ^a   Quirion, Rémi ^a  

^a MCGILL UNIVERSITY   (Canada)

^b HÔPITAL SAINT ANTOINE   (France)

^c SANOFI   (France)

Author keywords

Adrenal steroids; Corticotropin releasing hormone; Neurotensin; Paraventricular nucleus; Stress

Indexed keywords

2 [[1 (7 CHLORO 4 QUINOLINYL) 5 (2,6 DIMETHOXYPHENYL) 3 PYRAZOLYL]CARBONYLAMINO] 2 ADAMANTANECARBOXYLIC ACID; CORTICOSTERONE; CORTICOTROPIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CIRCADIAN RHYTHM; CORTICOSTERONE BLOOD LEVEL; CORTICOTROPIN BLOOD LEVEL; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMOBILIZATION STRESS; MALE; MEDIAN EMINENCE; NONHUMAN; PRIORITY JOURNAL; RAT; THALAMUS MIDLINE NUCLEUS;

ANIMALS; CIRCADIAN RHYTHM; CORTICOTROPIN-RELEASING HORMONE; DRUG IMPLANTS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MALE; MEDIAN EMINENCE; NEUROTENSIN; ORGAN SIZE; PARAVENTRICULAR HYPOTHALAMIC NUCLEUS; PITUITARY-ADRENAL SYSTEM; PYRAZOLES; QUINOLINES; RADIOIMMUNOASSAY; RATS; RECEPTORS, NEUROTENSIN; STRESS, PSYCHOLOGICAL; TRANSCORTIN;

EID: 0030840945     PISSN: 00283835     EISSN: 14230194     Source Type: Journal    
DOI: 10.1159/000127223     Document Type: Article

References (67)

1. St. Pierre SA, Kerouac R, Quirion R, Jolicoeur FB, Rioux F: Neurotensin. Peptides Protein Rev 1984;2:83-172.
2. Maeda K, Frohman LH: Dissociation of systemic and central effects of neurotensin on the secretion of growth hormone, prolactin and thyrotropin. Endocrinology 1978:103:1903-1909.
3. Vijayan E, McCann SM: In vivo and in vitro effects of substance P and neurotensin on gonadotropin and prolactin release. Endocrinology 1979:105:64-68.
4. McCann SM, Vijayan E, Kocinig J, Krulich L: The effects of neurotensin on anterior pituitary hormone secretion. Ann NY Acad Sci 1982: 400:160-171.
5. Abe HK, Chihara T, Chiba S, Matsukura S, Fujita T: Effect of intravcntricular injection of neurotensin and other various bioactive peptides on plasma immunoreactive somatostatin levels in rat hypophysial portal blood. Endocrinology 1981;108:1939-1943.
6. Akema T, Kimura F: Inhibition by catacho-laminergic blockers of the neurotensin-induced enhancement of luteinizing hormone secretion in the ovarectomized estrogen-primed rat. Ncuroendocrinology 1989:50:688-692.
7. Alexander MJ, Mahoney PD, Ferris CF, Carra-way RE, Leeman SE: Evidence that neurotensin participates in the central regulation of the preovulatory surge in luteinizing hormone in the rat. Endocrinology 1989;124:783-788.
8. Kahn D, Abrams GM, Zimmerman EA, Carra-way R, Leeman SE: Neurotensin neurons in the rat hypothalamus: An immunohistochemical study. Endocrinology 1980:107:47-54.
9. Kahn D, Hou-Yu A, Zimmerman EA: Localization of neurotensin in the hypothalamus. Ann NY Acad Sci 1982:400:117-131.
10. Jennes L, Stumph WE, Kalivas PW: Neurotensin: Topographical distribution in rat brain by ¡mmunocytochcmistry. J Comp Neurol 1982; 210:211-214.
11. Ceccatelli S, Ericksson MI, Idkfelt T: Distribution and coexistence of corticotropin-releasing factor, neurotensin, enkephalin, cholccysloki-nin. galanin and vassoactivc intestinal polypeptide/peptide histidine isolcucine-like peptides in the parvocellular part of the paraventricular nucleus. Neuroendocrinology 1989:49: 309-323.
12. Sawchcnko PE, Swanson LW, Vale WW: Corticotropin-releasing factor coexpression within distinct subsets of oxytocin-, vasopressin-, and neurotensin immunoreactivc neurons in the hypothalamus of the male rat. J Neurosci 1984: 4:1118-1129.
13. Hokfelt T, Everitt BJ, Theodorsson-Norheim E, Goldstein M: Occurrence of neurotensin-like immunoreactivity in subpopulations of hypothalamic. mesencephalic and medullary catecholamine neurons. J Comp Neurol 1984:222: 543-560.
14. Nicot A, Berod A, Gully D, Rowe W, Quirion R, De Kloet R, Rostenc W: Anatomical substrate for neurotensin action on the hypotha-lamic-pituitary-adrenal axis and pharmacological blockade with a non-peptide neurotensin receptor antagonist. Neuroendocrinology 1994:59:572-578.
15. Nicot A, Rostene W, Berod A: Neurotensin receptor expression in the rat forebrain and midbrain: A combined in situ hybridization and receptor autoradiography study. J Comp Neurol 1994:341:407-419.
16. Fuxc K, Agnati L, Andersson K, Encroth P, Horfstrand A, Goldstein M, Zoli M: Studies on ncurotcnsin-catecholamine interactions in the hypothalamus and in the forebrain of the male rat. Neuroehcm Int 1984;6:737-750.
17. Gudelsky GA, Berry SA, Mclter HY: Neurotensin activates tuberoinfundibular dopamine neurons and increases scrum corticosterone concentrations in the rat. Neuroendocrinology 1989:48:604-609.
18. Rowe W, Viau V, Mcancy MJ, Quirion R: Central administration of neurotensin stimulates hypothalamic-pituitary-adrenal activity. Ann NY Acad Sci 1992:668:365-367.
19. Rowe W, Viau V, Meaney MJ, Quirion R: Stimulation of CRH-mediated ACTH secretion by central administration of neurotensin: Evidence for the participation of the paraventricular nucleus. J Neuroendocrinol 1995:7: 109-117.
20. 11 Ineurotensin, a highly radioactive ligand for neurotensin receptors. J BiolChem 1983:258:3476-3481.
21. Kitabgi P, Checler F, Mazella J, Vincent JP: Pharmacology and biochemistry of neurotensin receptors. Rev Basic Clin Pharmacol 1985; 5:397-486.
22. Tanaka KM, Masu M, Nakanishi S: Structure and functional expression of the cloned rat neurotensin receptor. Neuron 1990:4:847-854.
23. Gilbert JA, Richelson E: Neurotensin stimulates cyclic GMP in murine neuroblastoma clone NIE-115. EurJ Pharmacol 1984:99:245-246.
24. Goedert M, Pinnock RD, Downes CP, Mantyh PW, Emson PC: Neurotensin stimulates inositol phospholipid hydrolysis in rat brain slices. Brain Res 1984:323:193-197.
25. Gully D, Canton M, Boigegrain R, Jeanjean F, Molimard J-C, Poncelct M, Gueudet C, Hcaulmc M, Lcyris R, Brouard A, Pélaprat D, Labbé-Jullic C, Mazella J, Soubrié P, Maflrand JP, Rostènc W, Kitabgi P, Le Fur G: Biochemical and pharmacological profile of a potent and selective nonpcptidc antagonist of the neurotensin receptor. Proc Natl Acad Sci USA 1993; 90:65-69.
26. Pugsley TA, Akunnc HC, Whetzel SZ, Demaltos A, Corbin E, Wiley JN, Wustrow DJ, Wise LD, Heffner TG: Differential effects of the nonpeptide neurotensin (NT) antagonist. SR 48692, on the pharmacological effects of NT agonists. Peptides 1995; 16:37-44.
27. Steinberg R, Brun P, Fournier M, Souilhae J, Rodier D, Mons G, Terranova JP, LeFur G, Soubric P: SR 48692. a nonpeptide neurotensin receptor antagonist differentially affects neurotensin-induced behavior and changes in dopaminergic transmission. Neuroscience 1994:59:921-929.
28. Poncelet M, Souilac J, Gueudet C, Terranova JP, Gully D, Le Fur G, Soubric P: Effects of SR 48692. a selective non-peptide neurotensin receptor antagonist, on two dopamine dependent behavioral responses in mice and rats. Psychopharmacology 1994:116:237-241.
29. Watts AG: Ether anesthesia differentially affects the content of preprocorticolropin-rclcas-ing hormone, prepro-neurolcnsin/neuromcdin N and prepro-enkephalin mRNAs in the hypothalamic paraventriular nucleus of the rat. Brain Res 1991:544:353-357.
30. Ccccatclli S, Orazzo C, Hokfelt T: Effect of different types of stressors on peptide mRNAs in the hypothalamic paraventricular nucleus. Acta Endocrinol 1993:128:485-492.
31. Paxinos G, Watson C: The Rat Brain in Stereotaxic Coordinates, ed 2. Sydney. Academic Press. 1986.
32. Meaney MJ, Aitken DII, Sharma S, Viau V: Basal ACTH. corticosterone, and corticosterone-binding globulin levels over the diurnal cycle, and hippocampal type I and type II corticosteroid receptors in young and old. handled and nonhandled rats. Ncurocndocrinology 1992:55:204-213.
33. Abercrombie M: Estimations of nuclear populations from microtome sections. Anat Rcc 1946:94:239-247.
34. Palkovits M, Brownstein MJ: Maps and Guide to Microdissection of the Rat Brain. New York. Elsevier. 1988.
35. Bradford M: A rapid and sensitive method for quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976:72:248-254.
36. Martin CE, Cake MN, Hartmann PE, Cook IF: Relationship between foetal corticosteroids, maternal progesterone and parturition in the rat. Acta Endocrinol (Copenh) 1977:84:167-176.
37. Hardsell U-K, Rowe W, Sharma S, Meaney MJ, Quirion R: Hypothalamic-pituitary-adrenal activity during chronic central administration of interleukin-2. Endocrinology 1994:135: 2465-2472.
38. Plvmatc SR, Vaughan GM, Mason AD, Pruitt BA: Central hypogonadism in burned men. Horm Res 1987:27:152-158.
39. Philibert D, Moguilcwski M: RU 28362. A useful tool for the characterization of glucocorticoid and mincralocorticoid receptors. Endocr SocAbstr 1983:9:335.
40. Coirini H, Magarinos AM, DeNicola AF, Rainbow TC, McEwan BS: Further studies of brain aldosterone binding sites employing new min-eralocorticocorticoid and glucocorticoid receptor markers in vitro. Brain Res 1985:361:212-217.
41. Tallarida RJ, Murray RB: Area under a curve: Simpson's rule and trapezoidal rule: in Tallarida RJ. Murray RB (eds): Manual of Pharmacological Calculations with Computer Programs. New York, Springer, 1981, pp 47-49.
42. Carnes M, Lent SJ, Goodman B, Mueller C, Saydoff J, Erisman S: Effects of immunoneu-tralization of corticotropin-releasing hormone on ultradian rhythms of plasma adrenocortico-tropin. Endocrinology 1990:126:1904-1913.
43. Rivier C, Rivier J, Vale W: Inhibition of adrenocorticotropic hormone secretion in the rat by immunoneutralization of corticotropin-releasing factor. Science 1982:218:377-379.
44. Swanson LW, Sawchcnko PE. Rivier J, Vale WW: The organization of ovine corticotropin releasing factor (CRF)immunorcactive cells and fibers in the rat brain: An immunohisto-chemical study. Neuroendocrinologv 1983:37: 64-72.
45. Swanson IW, Sawchcnko PE, Rivier J, Vale W: Organization of ovine corticotropin-releasing cells and fibers in the rat brain: An intmu-nohistochemical study. Neuroendocrinology 1983;36:165-186.
46. Moga MM, Saper CB: Neuropeptide-immuno-reactive neurons projecting to the paraventricular hypothalamic nucleus in the rat. J Comp Neurol 1994:346:137-150.
47. Watts AG, Sanchez-Watts G: Physiological regulation of peptide messanger RNA colocalization in rat hypothalamic paraventricular medial parvoccllular neurons. J Comp Neurol 1995:352:501-514.
48. Makino S, Smith MA, Gold PW: Increased expression of corticotropin-releasing hormone and vasopressin messenger ribonucleic acid (mRNA) in the hypothalamic paraventricular nucleus during repeated stress: Association with reduction in glucocorticoid receptor mRNA levels. Endocrinology 1995:136:3299-3309.
49. Plotskv PM, Meaney MJ: Early, postnatal handling alters hypothalamic corticotropin-releasing factor (CRF) mRNA. median eminence CRF content and stress-induced release in adult rats. Brain Res Mol Brain Res 1993:18: 195-200.
50. Harbuz MS, Jessop DS, Lightman SL, Chow-drev HS: The effects of restraint or hypertonic saline stress on corticotropin-releasing factor, arginine vasopressin, and proenkephalin A mRNAs in CFY. Sprague-Dawley and Wistar strains of rat. Brain Res 1994;667:6-12.
51. Intaki T, Xiao-Quan W, Shibasaki T, Yamada K, Harada S, Chikada N, Naruse M, Demura H: Stress-induced activation of neuronal activity and corticotropin-releasing factor gene expression in the paraventricular nucleus is modulated by glucocorticoids in rats. J Clin Invest 1995:96:231-238.
52. Intaki T, Shibasaki T, Wang XQ, Demura H: Intraccrcbrovcntricular administration of corticotropin-releasing factor antagonist attenu-atesc-fos mRNA expression in the paraventricular nucleus after stress. Neuroendocrinology 1995;61:445-452.
53. Kjaer A, Knigge U, Bach FW, Warberg J: Impaired histamine- and stressinduced secretion of ACTH and beta-endorphin in vasopressin-deficient Brattleboro rats. Neuroendocrinology 1993:57:1035-1041.
54. Nicot A, Rowe W, De Kloet ER, Jessop DS, Lightman SL, Quirion R, Rostene W, Berod A: Endogenous neurotensin regulates hvpotha-lamic-pituitary-adrcnal axis activity and peptidergic neurons in the rat hypothalamic paraventricular nucleus. J Neuroendocrinology 1997. in press.
55. Roberts GW, Woodhams PL, Polak JM, Crow TJ: Distribution of neuropeptides in the limbic system of the rat: THc amygdaloid complex. Neuroscience 1982:7:99-131.
56. Emson PC, Goedert M, Horsfield P, Rioux F, St-Picrre S: The regional distribution and chromatographic characterization of neurotensin-like immunoreactivity in the rat central nervous system. J Neurochem 1982:38:992-1000.
57. Alexander MJ, Miller MA, Dorsa DM, Bullock BP, Mclloni RH, Dobner PR, Leeman SE: Distribution of ncurotcnsin/ncuromcdian N mRNA in the rat forebrain: Unexpected abundance in hippocampus and subiculum. Proc Natl Acad Sci USA 1989:86:5202-5206.
58. Vincent JP: Neurotensin receptors: Binding properties, transduction pathways, and structure. Cell Mol Neurobiol 1995:15:501-512.
59. Poinot-Chazcl C, Portier M, Bouaboula M, Vita N. Peeccu F, Gully D, Monroe JG, Maf-frand JP. Le Fur G, Casellas P: Activation of mitogen-activated protein kinase couples neurotensin receptor stimulation to induction of the primary response gene Krox-24. Biochem J 1996:320:145-151.
60. Rivest S, Rivier C: Influence of the paraventricular nucleus of the hypothalamus in the alteration of neuroendocrine functions induced by intermittent footshock or interleukin. Endocrinology 1991:129:2049-2056.
61. Spencer RL, McEwen BS: Adaptation of the hypolhalamic-pituitary-adrcnal axis to chronic ethanol stress. Neuroendocrinology 1990:52: 481-489.
62. Scribner KA, Akana SF, Walker C-D, Dallman MF: Streptozotocin-diabctic rats exhibit facilitated adrcnocorticotropin responses to acute stress, but normal sensitivity to feedback by corticosteroids. Endocrinology 1993:133: 2667-2674.
63. Meaney MJ, Aitken DH, Sharma S, Viau V, Sarrieau A: Postnatal handling increases glucocorticoid receptors and enhances adrenocortical negative-fcedback efficacy in the rat. Neuroendocrinology 1989:50:597-604.
64. Quirion R, Rioux F, St-Pierre S, Belanger F, Jolicoeur FB, Barbeau A: Hypotensive effects of centrally and peripherally administered neurotensin derivatives in rats. Neuropeptides 1981;1:253-259.
65. Sumners C, Phillips ML Richard EM: Central pressor action of neurotensin in conscious rats. Hypertension 1982:4:888-893.
66. Bagdan B, Pittman QJ: Responses of electro-physiologically identified rat paraventricular neurons to cholccvstokinin and other stimuli. Neuroscience 1995;65:869-878.
67. Graham JC, Hoffman GE, Sved AF: c-Fos expression in brain in response to hypotension and hypertension in conscious rats. J Auton NcrvSyst 1995:55:92-104.